NCT06439082 · Interventional trial
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Overall registry status Recruiting
Phase 3
Conditions Sickle Cell Disease
Delaware Valley sites
- Thomas Jefferson University Me · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory